The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 351:1170-1172 September 16, 2004 Number 12
NextNext

Changing the Cell Source in Cell Therapy?
Graziella Pellegrini, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Nishida, K.
-PubMed Citation
One dream of scientists is to be able to rebuild, in vitro, "spare parts" to replace injured or diseased tissues — a notion that was once relegated to the realm of science fiction. The concept that stem cells that are ostensibly site-specific can give rise to (and maintain) mature tissues has made adult stem cells the focus of intense research designed to explore their promise for the treatment of a variety of human diseases.

Adult stem cells are defined as clonogenic, self-renewing progenitor cells that can generate one or more specialized types of cells. However, major obstacles in this field . . . [Full Text of this Article]


Source Information

From the Veneto Eye Bank Foundation, Epithelial Stem Cell Research Center, Ospedale Civile di Venezia, Venice, Italy.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved.